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INTRODUCTION
According to the International Continence 
Society, urinary incontinence (UI) is defined 
as ‘the complaint of any involuntary leakage 
of urine’.1 The global prevalence of UI is 
3–17% in females and 3–11% in males, 
with varying prevalence across countries.2 
Although it is most common in older adults, 
the condition can affect people of all ages. 
For example, in a study carried out in 
nulliparous females, the incidence of UI 
increased from 3% in those aged 25–34 years 
to 7% in those aged 55-64 years.3 Moreover, 
another study found that the prevalence 
of moderate–severe UI in community-
dwelling females was 7%, 17%, 23%, and 
32% in those aged 20–39, 40–49, 60–79, and 
≥80 years, respectively.4 In studies carried 
out on males and females, the prevalence 
of UI was found to be between 11–34% in 
males aged >65 years, and about twice 
that frequency in females, proving that UI is 
more common in females than males.5 UI is 
associated with impaired quality of life6 and 
imposes a tremendous economic burden 
on national health services/systems.7
Multimorbidity is defined as the 
simultaneous occurrence of ≥2 chronic 
diseases in one person and can include both 
physical and mental health complications. It 
has been found that in developed countries 
>40% of the population have ≥1 chronic 
condition, and approximately 25% have >1 
condition (that is, multimorbidity).8 Similar 
to UI, multimorbidity is most common 
among older adults, but can affect people 
of all ages.9 Multimorbidity is a public 
health concern as it has been shown to be 
associated with high mortality,10 reduced 
functional status,11 and increased use 
of both inpatient and ambulatory health 
care.12,13 Multimorbidity is more difficult 
to manage than singular conditions, 
and requires close coordination across 
specialists and generalists.
Owing to a multifactorial aetiology behind 
UI and that cognitive, neurological, muscular, 
and urological systems must be robust to 
maintain continence,14,15 one can assume a 
relatively high prevalence of UI in people with 
multimorbidity. However, literature in this 
area is scarce. In one study of 622 Brazilian 
females aged ≥50 years it was found 
that approximately two-thirds of females 
suffering from UI reported multimorbidity.16 
The authors of the present study are not 
Abstract
Background
One can assume a relatively high prevalence 
of urinary incontinence (UI) in people with 
multimorbidity. However, literature in this area 
is scarce. There is a need for further robust 
research to aid GPs to identify patients at a 
particular risk for UI, and to initiate the early 
treatment and multidisciplinary management 
of this condition.
Aim
To examine the association between 
multimorbidity and UI in 23 089 individuals aged 
≥15 years and residing in Spain.
Design and setting
This study used data from the Spanish National 
Health Survey 2017, a cross-sectional sample 
of 23 089 participants aged ≥15 years residing 
in Spain (54.1% female; mean [standard 
deviation] age = 53.4 [18.9] years). 
Method
UI and 30 other physical and mental chronic 
conditions were self-reported. Multimorbidity 
was defined as the presence of ≥2 physical and/
or mental chronic conditions (excluding UI). 
Control variables included sex, age, marital 
status, education, smoking, and alcohol 
consumption. Multivariable logistic regression 
analyses were conducted to assess the 
association between multimorbidity and UI.
Results
The prevalence of UI was 5.9% in this sample. 
UI was more frequent in the presence than 
in the absence of each one of the 30 chronic 
conditions (P<0.001). The proportion of people 
with UI was also higher in the multimorbidity 
than in the no-multimorbidity group (9.8% 
versus 0.7%, P<0.001). After adjusting for 
several potential confounders (that is, sex, 
age, marital status, education, smoking, and 
alcohol), there was a significant and positive 
relationship between multimorbidity and UI 
(odds ratio = 5.02, 95% confidence interval 
[CI] = 3.89 to 6.59, P<0.001).
Conclusion
In this large sample of Spanish individuals aged 
≥15 years, suffering from multimorbidity was 
associated with a significantly higher level of UI.
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aware of any other literature on this topic. 
Clearly there is a need for further research 
investigating the association between 
multimorbidity and UI in population-based 
samples, among people of multiple ages and 
from other countries, to establish a better 
understanding of this topic as well as the 
underlying risk factors for UI. Consequently, 
this would help GPs to identify patients 
at particular risk for UI, and to initiate 
the early treatment and multidisciplinary 
management of this condition. Therefore, 
the aim of the present study was to examine 
the association between multimorbidity 




Data from the Spanish National Health 
Survey 2017 were analysed. This survey was 
undertaken in Spain between October 2016 
and October 2017. Details of the survey 
method have been already published.17 For 
the data collection, a stratified three-stage 
sampling was used in which the census 
sections were first considered, followed by 
the family dwellings, and then an individual 
aged ≥15 years was selected within each 
dwelling. The sections were selected within 
each stratum with probability proportional 
to their size. After arrangement by the 
size of the dwellings, the dwellings in 
each section were selected with equal 
probability by systematic sampling. This 
procedure leads to self-weighting samples 
in each stratum. For the selection of the 
person who had to complete the adult 
questionnaire, the random Kish method 
was used, which assigns equal probability 
to all adults in the household. The sample 
consisted of 23 089 individuals aged 15–103 
years residing in Spain. There were no 
exclusion criteria in the present study, and 
the overall sample was included in the 
statistical analyses. The method of data 
collection used was computer-assisted 
personal interviewing (CAPI), conducted in 
the homes of the selected participants. The 
interviewers, previously trained, completed 
the questionnaires with the information 
provided by the participants. All of them 
signed an informed consent form before 
responding to the survey questions.
Multimorbidity (independent variable)
Multimorbidity was defined as the presence 
of ≥2 chronic conditions (excluding UI). 
Those who answered affirmatively to 
the yes/no question ‘Have you ever been 
diagnosed with ‘chronic condition’?’ were 
considered to have the specific chronic 
condition. All conditions except obesity 
were assessed with this question. Previous 
research has confirmed the validity and 
high accuracy of self-reported diagnosis of 
chronic conditions.18,19 Using the standard 
World Health Organization (WHO) definition, 
obesity was defined as body mass index 
(BMI) ≥30 kg/m2, and BMI <30 kg/m2 
was considered no obesity.20 BMI was 
calculated as weight in kilograms divided 
by height in metres squared based on self-
reported weight and height. The chronic 
conditions that were included are listed in 
Box 1 classified following the International 
Classification of Diseases, 11th Revision 
(ICD-11), of the WHO.
UI (dependent variable)
Those who answered affirmatively to the 
question ‘Have you ever been diagnosed 
with UI?’ were considered to have UI. 
Previous research has confirmed the 
validity and high accuracy of self-reported 
diagnosis of UI.22
Control variables
The selection of the control variables was 
based on previous studies showing that 
these factors are associated with both 
the independent23–27 and the dependent 
variable.28–31 Sociodemographic variables 
included sex, age, marital status, and 
education. Marital status was categorised 
as married and not married (single/
widowed/divorced/separated). Education 
was based on the highest educational level 
achieved and was categorised as ≤primary, 
secondary, and ≥tertiary. Smoking status 
was self-reported and categorised as 
never, past, and current smoking. Alcohol 
consumption in the past 12 months was 
self-reported and categorised as yes (any) 
and no (none).
Statistical analysis
The statistical analysis was performed with 
R 3.5.2 (the R Foundation, https://www.r-
project.org). All the analyses were carried 
How this fits in
Understanding multimorbidity and urinary 
incontinence (UI) is critical for medical 
practitioners. This study found that UI was 
more frequent in the presence than in the 
absence of chronic conditions. Those with 
multimorbidity were five times more likely 
to suffer from UI. GPs should be aware 
that those with multimorbidity are at an 
increased risk of UI.
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out taking into account the cross-sectional 
design of the survey, using appropriate tests 
for this design. Differences in the sample 
characteristics (by multimorbidity status) 
and in the prevalence of UI (by chronic 
condition and multimorbidity status) were 
assessed by χ² tests for all variables except 
age (t-test). The association between 
multimorbidity (independent variable) and 
UI (dependent variable) was assessed 
using multivariable logistic regression. 
Independent variables were included in the 
models as categorical variables with the 
exception of age, which was included as a 
continuous variable. UI was included in the 
model as dichotomous variable. Models 
were adjusted for basic sociodemographic 
and behavioral variables (that is, sex, 
age, marital status, education, smoking, 
alcohol).23–31 There were missing data for 
the following variables only: marital status 
(n = 39, 0.17%), smoking (n = 22, 0.10%), 
alcohol consumption (n = 26, 0.11%), and 
obesity (n = 1070, 4.63%). Complete-case 
analysis was carried out. Results from the 
logistic regression analyses are presented 
as odds ratios (ORs) and 95% confidence 
intervals (CIs). Confidence intervals 
and P-values were corrected using the 
Benjamini–Yekutieli and the Benjamini–
Hochberg procedures to control the false 
discovery rate. The level of statistical 
significance was set at P<0.05. 
RESULTS
There were 23 089 individuals aged 
≥15 years included in this cross-sectional 
study (54.1% of females; mean (standard 
deviation) age = 53.4 (18.9) years; Table 1). 
The proportion of females, married 
individuals, people with ≤primary 
education, past smokers, and people 
with no alcohol consumption was more 
frequent in the multimorbidity than in 
the no-multimorbidity group, whereas 
people with multimorbidity were older 
than those without multimorbidity. The 
prevalence of UI was 5.9% in this sample. 
UI was more frequent in the presence 
than in the absence of each one of the 
30 chronic conditions (P<0.001; Figure 1). 
The proportion of people with UI was also 
higher in the multimorbidity than in the 
no-multimorbidity group (9.8% versus 0.7%, 
P<0.001). The results of the regression 
analysis are displayed in Table 2. After 
adjusting for several potential confounders 
(that is, sex, age, marital status, education, 
smoking, alcohol), there was a significant 
and positive relationship between 
multimorbidity and UI (odds ratio = 5.02, 
CI = 3.89 to 6.59, P<0.001).
DISCUSSION
Summary
In this large sample of the Spanish 
population, it was found that the prevalence 
of UI was 5.9%. Moreover, those with 
multimorbidity were five times more likely 
to suffer from UI. These findings support 
previous literature where another study 
showed in a small sample of Brazilian 
females that approximately two-thirds of 
those with UI suffered from multimorbidity.16 
The present study adds to this literature by 
showing that such an association exists in a 
large sample of males and females residing 
in Spain. 
Strengths and limitations
The present study investigated the 
relationship between multimorbidity and 
UI in a large sample of males and females. 
However, the present findings must be 
Box 1. List of chronic conditions classified following the International 
Classification of Diseases, 11th Revision (ICD-11)21
Diseases of the circulatory system Hypertension 
 Myocardial infarction
 Angina pectoris and other coronary diseases
 Other cardiac diseases
 Varicose veins of lower extremities
Diseases of the nervous system Stroke
 Migraine and other frequent headaches
Diseases of the musculoskeletal system or connective Osteoarthritis
tissue Chronic neck pain
 Chronic low back pain
 Osteoporosis 
Diseases of the immune system Chronic allergy (excluding allergic asthma)
Diseases of the respiratory system Asthma (including allergic asthma)
 Chronic bronchitis, emphysema, or COPD
Diseases of the digestive system Liver cirrhosis and other hepatic disorders
 Peptic ulcer disease
 Chronic constipation 
 Haemorrhoids
Diseases of the genitourinary system Renal disease
Diseases of the visual system Cataract
Diseases of the skin Chronic skin disease
Mental, behavioural, or neurodevelopmental disorders Depression
 Anxiety disorder
 Other psychiatric disorders
Neoplasms Cancer




Injury, poisoning, or certain other consequences of Permanent injuries caused by an accident 
external causes 
COPD = chronic obstructive pulmonary disease.
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interpreted in light of the study limitations. 
Both UI and all chronic conditions were 
self-reported, potentially introducing 
bias. The stem question asked was ‘Have 
you ever been diagnosed with “chronic 
condition”?’ Owing to the wording of the 
question it is possible that a person used 
to have a specific chronic condition but 
no longer does, potentially inflating the 
prevalence of multimorbidity observed in 
this study. Furthermore, participants were 
only asked whether they suffered from UI 
and not the type of UI; different types of 
UI may have different associations with 
multimorbidity, and further research is now 
required to address this question. Data 
on duration of chronic conditions were 
not available, thus potentially introducing 
some bias into analyses. Moreover, there 
was no information on parity, although 
parity is a well known risk factor for UI in 
females. Data on those who received the 
invitation to participate in the survey and 
did not respond are not available. Moreover, 
there are no recent available national 
statistics to compare the present sample 
to. Therefore, the representativeness of the 
present sample is not known. Finally, the 
cross-sectional nature of the study means 
the direction of observed associations is 
not known. Therefore, future longitudinal 
studies are needed to clarify the direction of 
causality. Nevertheless, the mere coexisting 
presence of UI with chronic conditions and 
multimorbidity highlights an important 
health priority and informs targeted 
intervention.
Comparison with existing literature
In this large sample of the Spanish 
population, the prevalence of UI was 5.9% 
and the prevalence of multimorbidity was 
56.9%. This prevalence is comparable with 
existing literature. For example, a systematic 
review assessed the global prevalence 
of UI in different samples of adults from 
Europe, the United States, Asia, and Africa, 
obtaining varying UI prevalence estimates 
with ranges of 1.8–30.5% in European 
populations, 1.7–36.4% in US populations, 
and 1.5–15.2% in Asian populations, with 
prevalence dependent on age and sex.7 
Regarding the prevalence of multimorbidity, 
another systematic review including 
Figure 1. Prevalence of urinary incontinence by chronic 
condition and multimorbidity.a
aMultimorbidity was defined as the presence of two 
or more chronic conditions. Chronic conditions are 
listed in Box 1. Urinary incontinence and other chronic 
conditions except obesity were assessed with questions 
with ‘yes’ and ‘no’ options. BMI was calculated as 
weight in kilograms divided by height in meters 
squared based on self-reported weight and height. 
Using the standard WHO definition, obesity was defined 
as  BMI ≥30 kg/m2, and BMI <30 kg/-m2 was considered 
no obesity. Urinary incontinence was more frequent 
in the presence than in the absence of each one of 
the 30 chronic conditions or multimorbidity. P-values 
were based on χ2 tests and were corrected using the 
Benjamini–Hochberg adjustment method. All P-values 
were lower than 0.001 (not displayed in the figure). 
BMI = body mass index. COPD = chronic obstructive 
pulmonary disease. WHO = World Health Organization.




















Chronic bronchitis, emphysema, or COPD
Asthma (including allergic asthma)
Chronic allergy (excluding allergic asthma)
Chronic low back pain
Chronic neck pain
Osteoarthritis
Varicose veins of lower extremities
Other cardiac diseases





Presence of the chronic condition of interest Absence of the chronic condition of interest
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70 057 611 patients in 12 countries found 
a multimorbidity prevalence ranging from 
12.9–95.1%.32
There are several plausible mechanisms 
that likely increase risk of UI for those 
suffering from multimorbidity. First, 
changes in age-related immune functions, 
hormonal changes, and increasing 
incidence of comorbid diseases may 
facilitate urinary tract infections that can 
result in UI.33 Second, poor sleep quality34 is 
associated with nocturia (waking from sleep 
to void). Third, multimorbidity is associated 
with mild cognitive impairment35,36 and 
with cognitive decline37 and, in turn, those 
with a dementia diagnosis (a condition 
not available to the present study) have 
approximately three times the rate of 
diagnosis of UI.38 Fourth, another possible 
mechanism is polypharmacy (often defined 
as the prescription of ≥5 different drugs), 
as polypharmacy is strongly associated 
with multimorbidity,39 while the frequency 
of polypharmacy is high among patients 
attending a specialist outpatient department 
for UI.40 Fifth, sarcopenia could also have a 
mediating role in the association between 
multimorbidity and UI, as previous studies 
have found associations of sarcopenia 
with both multimorbidity41 and UI.42 Sixth, 
another important factor is physical activity, 
as less physical activity is associated with a 
higher prevalence of multimorbidity43 and 
UI.44
Implications for practice
Understanding multimorbidity and UI is 
critical for medical practitioners. First, in 
managing multimorbidity, UI can easily 
be overlooked or eclipsed by other more 
pressing complaints, especially if patients 
feel too embarrassed to mention the topic. 
In this case, it is incumbent upon the 
medical provider to elicit this information 
from the patient. These findings suggest 
that UI should become a standard feature of 
clinical interviews, given that treatment for 
UI could involve a number of interventions 
(for example, pelvic floor exercises, 
medications, surgery, medical devices) 
that must figure into already complicated 
treatment plans for patients with 
multimorbidity. Second, UI is associated 
with significant impairment in occupational, 
social, sexual, and recreational functioning. 
That is, daily activities may be constrained 
by geographic proximity to bathrooms. 
Patients with multimorbidity may already 
face significant impairment from multiple 
underlying conditions, and often treatment 
for these conditions aims to maximise 
overall functioning and independent living. 
Table 1. Sample characteristics (overall and by multimorbidity 
status)a
 Multimorbidity
  Overall 
Characteristics Category (N = 23 089) No (N = 9940) Yes (N = 13 149) P-valueb
Sex, %, n Male 45.9 (10 595) 51.7 (5141) 41.5 (5454) <0.001
 Female 54.1 (12 494) 48.3 (4799) 58.5 (7695) 
Age Mean (SD) 53.4 (18.9) 43.0 (16.0) 61.3 (17.0) <0.001
Marital status Single/widowed/ 45.9 (10 585) 47.4 (4701) 44.8 (5884) <0.001 
%, n divorced/separated
 Married 54.1 (12 465) 52.6 (5215) 55.2 (7250) 
Education, %, n ≤Primary 31.2 (7206) 15.4 (1532) 43.2 (5674) <0.001
 Secondary 43.0 (9936) 51.1 (5077) 37.0 (4859) 
 ≥Tertiary 25.8 (5947) 33.5 (3331) 19.9 (2616) 
Smoking, %, n Never 50.7 (11 707) 50.4 (5007) 51.0 (6700) <0.001
 Past 25.8 (5962) 21.3 (2114) 29.3 (3848) 
 Current 23.4 (5398) 28.3 (2807) 19.7 (2591) 
Alcohol, %, n No 35.8 (8260) 28.5 (2834) 41.3 (5426) <0.001
 Yes 64.1 (14 803) 71.4 (7094) 58.6 (7709) 
aMultimorbidity was defined as the presence of two or more chronic conditions. Chronic conditions are listed in 
Box 1. All conditions except obesity were assessed with questions with ‘yes’ and ‘no’ options. BMI was calculated 
as weight in kilograms divided by height in meters squared based on self-reported weight and height. Using the 
standard WHO definition, obesity was defined as BMI ≥30 kg/m2, and BMI< 30 kg/m2 was considered no obesity. 
Values are % (N) unless otherwise stated. bP-values were based on χ² tests except for age (t-test), and were 
corrected using the Benjamini–Hochberg procedure. BMI = body mass index. SD = standard deviation. Tertiary 
education: known as third-level, third-stage, or post-secondary education. WHO = World Health Organization.
Table 2. Association between multimorbidity (independent variable) 
and urinary incontinence (dependent variable) in adults residing in 
Spaina
Characteristics Category Odds ratio 95% CIb P-valuec
Multimorbidity No Reference  
 Yes 5.02 3.89 to 6.59 <0.001
Sex Male Reference  
 Female 1.20 1.03 to 1.40 0.020
Age One-unit increase 1.06 1.05 to 1.06 <0.001
Marital status Single/widowed/divorced/separated Reference  
 Married 0.96 0.84 to 1.09 0.498
Education  ≤Primary Reference  
 Secondary 0.74 0.63 to 0.87 <0.001
 ≥Tertiary 0.64 0.51 to 0.79 <0.001
Smoking Never Reference  
 Past 1.36 1.15 to 1.60 <0.001
 Current 1.13 0.90 to 1.41 0.279
Alcohol No Reference  
 Yes 0.73 0.64 to 0.84 <0.001
aMultimorbidity was defined as the presence of two or more chronic conditions. Chronic conditions are listed in Box 
1. Urinary incontinence and other chronic conditions except obesity were assessed with questions with ‘yes’ and 
‘no’ options. BMI was calculated as weight in kilograms divided by height in meters squared based on self-reported 
weight and height. Using the standard WHO definition, obesity was defined as BMI ≥30 kg/m2, and BMI <30 kg/ m2 
was considered no obesity. Models were adjusted for sex, age, marital status, education, smoking, and alcohol. 
bConfidence intervals were corrected using the Benjamini–Yekutieli adjustment method. cP-values were corrected 
using the Benjamini–Hochberg adjustment method. BMI = body mass index. CI = confidence interval. Tertiary 
education: known as third-level, third-stage, or post-secondary education. WHO = World Health Organization.
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The presence of UI can interfere with this 
treatment aim. Third, UI is associated with 
falls and other injuries that are especially 
concerning if occurring among people with 
multimorbidity, given that they are already 
physically vulnerable, and may likely suffer 
more serious injuries or take longer to 
recover. Taking that into account, addressing 
UI may help prevent further injury.
In conclusion, in this large sample of 
Spanish individuals aged ≥15 years, suffering 
from multimorbidity was associated 
with a significantly higher increased risk 
of UI. Interventions specifically designed 
for those with multimorbidity to reduce 
or manage co-occurring UI are required. 
Finally, urologists and GPs should be aware 
that those with multimorbidity are at an 
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